Related Experiment Video
Updated: Apr 15, 2026
12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
19.5K
[New technologies in diabetology. How far are we from a closed loop?]
1Institut für Diabetes-Technologie, Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm, Helmholtzstr. 20, 89081, Ulm, Deutschland, guido.freckmann@uni-ulm.de.
Der Internist
|April 15, 2015
Summary
Assistive diabetes technologies, including insulin pumps and continuous glucose monitors, are advancing rapidly. Future developments focus on an artificial pancreas for automated insulin delivery, with partially automated systems expected first.
Area of Science:
- Biomedical Engineering
- Endocrinology
- Medical Technology
Context:
- Diabetes management, particularly type 1 diabetes, relies heavily on assistive technologies.
- Insulin pumps are a standard treatment, offering advanced features like basal rate profiles and bolus calculators.
- Continuous glucose monitoring (CGM) systems are increasingly integrated with insulin delivery devices.
Purpose:
- To provide an overview of the current advancements in diabetes technology.
- To highlight the development of artificial pancreas systems and sensor-augmented insulin pumps.
- To discuss the progression towards automated insulin delivery solutions.
Summary:
- Modern insulin pumps feature sophisticated functions and connectivity with glucose monitoring devices.
- Continuous glucose monitoring sensors are becoming more refined and minimally invasive.
- Research is actively pursuing the integration of pumps and sensors to create an artificial pancreas for automated glucose regulation.
Impact:
- The development of an artificial pancreas promises more effective and automated diabetes management.
- Partially automated systems requiring user input are anticipated as an intermediate step before full automation.
- These technological advancements aim to improve the quality of life for individuals with diabetes.
Related Concept Videos
01:17Open and closed-loop control systems
2.1K
Control systems are foundational elements in automation and engineering. They are broadly categorized into open-loop and closed-loop systems. These classifications hinge on the presence or absence of feedback mechanisms, significantly influencing the system's performance, complexity, and application.
An open-loop control system operates without feedback from the output. It consists of two primary elements: the controller and the controlled process. The controller receives an input signal...
An open-loop control system operates without feedback from the output. It consists of two primary elements: the controller and the controlled process. The controller receives an input signal...
2.1K
01:15Diabetes: Management and Pharmacotherapy
1.5K
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.5K
01:01Feedback Loops
68.2K
In most cases, excessive hormone production is prevented by negative feedback—a loop that starts with a stimulus inducing the release of a particular substance, like a hormone, to maintain a certain level before triggering a signal that results in a decrease in further release of the hormone.
68.2K
01:20Pathophysiology of Diabetes
4.6K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
4.6K
01:22Diabetes Mellitus: Overview and Type I Subtype
6.3K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
6.3K
01:15Diabetes: Symptoms, Diagnosis, and Complications
2.9K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.9K